Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11. https://doi.org/10.1002/art.37715.
Article CAS PubMed Google Scholar
Rossi CM, Di Comite G. The clinical spectrum of the neurological involvement in vasculitides. J Neurol Sci. 2009;285(1–2):13–21. https://doi.org/10.1016/j.jns.2009.05.017.
Audemard-Verger A, Terrier B, Dechartres A, Chanal J, Amoura Z, Le Gouellec N, et al. Characteristics and management of IgA vasculitis (Henoch-Schonlein) in adults: data from 260 patients included in a French multicenter retrospective survey. Arthritis Rheumatol. 2017;69(9):1862–70. https://doi.org/10.1002/art.40178.
Article CAS PubMed Google Scholar
Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum. 2005;35(3):143–53. https://doi.org/10.1016/j.semarthrit.2005.08.007.
Saulsbury FT. Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore). 1999;78(6):395–409. https://doi.org/10.1097/00005792-199911000-00005.
Article CAS PubMed Google Scholar
Audemard-Verger A, Pillebout E, Guillevin L, Thervet E, Terrier B. IgA vasculitis (Henoch-Shonlein purpura) in adults: diagnostic and therapeutic aspects. Autoimmun Rev. 2015;14(7):579–85. https://doi.org/10.1016/j.autrev.2015.02.003.
Article CAS PubMed Google Scholar
Kauffmann RH, Herrmann WA, Meÿer CJ, Daha MR, Van Es LA. Circulating IgA-immune complexes in Henoch-Schönlein purpura. A longitudinal study of their relationship to disease activity and vascular deposition of IgA. Am J Med. 1980;69(6):859–66. https://doi.org/10.1016/s0002-9343(80)80011-8.
Article CAS PubMed Google Scholar
Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001;38(4):736–43. https://doi.org/10.1053/ajkd.2001.27690.
Article CAS PubMed Google Scholar
Hirano K, Matsuzaki K, Yasuda T, Nishikawa M, Yasuda Y, Koike K, et al. Association between tonsillectomy and outcomes in patients with immunoglobulin a nephropathy. JAMA Netw Open. 2019;2(5): e194772. https://doi.org/10.1001/jamanetworkopen.2019.4772.
Article PubMed PubMed Central Google Scholar
Kidney Disease: Improving Global Outcomes Glomerular Diseases Work G. KDIGO. Clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100(4S):S1–276. https://doi.org/10.1016/j.kint.2021.05.021.
Horie A, Hiki Y, Odani H, Yasuda Y, Takahashi M, Kato M, et al. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy. Am J Kidney Dis. 2003;42(3):486–96. https://doi.org/10.1016/s0272-6386(03)00743-1.
Article CAS PubMed Google Scholar
Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368(25):2402–14. https://doi.org/10.1056/NEJMra1206793.
Article CAS PubMed Google Scholar
Inoue CN. Tonsillectomy in the treatment of pediatric Henoch-Schönlein nephritis. Clin Nephrol. 2007;67(5):298–305. https://doi.org/10.5414/cnp67298.
Article CAS PubMed Google Scholar
Umeda C, Fujinaga S, Endo A, Sakuraya K, Asanuma S, Hirano D. Preventive effect of tonsillectomy on recurrence of Henoch-Schonlein purpura nephritis after intravenous methylprednisolone pulse therapy. Tohoku J Exp Med. 2020;250(1):61–9. https://doi.org/10.1620/tjem.250.61.
Sugiyama H, Watanabe N, Onoda T, Kikumoto Y, Yamamoto M, Maeta M, et al. Successful treatment of progressive Henoch-Schonlein purpura nephritis with tonsillectomy and steroid pulse therapy. Intern Med. 2005;44(6):611–5. https://doi.org/10.2169/internalmedicine.44.611.
Iwamoto M, Wakabayashi M, Hanada S, Kobayashi N, Hata T, Ando R. A case of Henoch-Schönlein purpura nephritis successfully treated with tonsillectomy and steroid pulse therapy. Nihon Jinzo Gakkai Shi. 2009;51(4):484–9.
Iwazu Y, Akimoto T, Muto S, Kusano E. Clinical remission of Henoch-Schonlein purpura nephritis after a monotherapeutic tonsillectomy. Clin Exp Nephrol. 2011;15(1):132–5. https://doi.org/10.1007/s10157-010-0345-5.
Marumoto H, Tsuboi N, Ueda H, Koike K, Hirano K, Kawamura T, et al. A case of IgA vasculitis that achieved clinical remission after tonsillectomy. Nihon Jinzo Gakkai Shi. 2020;62(2):92–100.
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92. https://doi.org/10.1053/j.ajkd.2008.12.034.
Article CAS PubMed Google Scholar
Suzuki Y, Matsuzaki K, Suzuki H, Sakamoto N, Joh K, Kawamura T, et al. Proposal of remission criteria for IgA nephropathy. Clin Exp Nephrol. 2014;18(3):481–6. https://doi.org/10.1007/s10157-013-0849-x.
Article CAS PubMed Google Scholar
Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, et al. Prognosis of Henoch-Schönlein nephritis in children. Br Med J. 1977;2(6078):11–4. https://doi.org/10.1136/bmj.2.6078.11.
Article CAS PubMed PubMed Central Google Scholar
Roberts IS, Cook HT, Troyanov S, Alpers CE, Working Group of the International Ig ANN, the Renal Pathology S, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76(5):546–56. https://doi.org/10.1038/ki.2009.168.
Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schonlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002;13(5):1271–8. https://doi.org/10.1097/01.asn.0000013883.99976.22.
Shi D, Chan H, Yang X, Zhang G, Yang H, Wang M, et al. Risk factors associated with IgA vasculitis with nephritis (Henoch-Schonlein purpura nephritis) progressing to unfavorable outcomes: a meta-analysis. PLoS One. 2019;14(10): e0223218. https://doi.org/10.1371/journal.pone.0223218.
Article CAS PubMed PubMed Central Google Scholar
Sevillano AM, Gutierrez E, Yuste C, Cavero T, Merida E, Rodriguez P, et al. Remission of hematuria improves renal survival in IgA nephropathy. J Am Soc Nephrol. 2017;28(10):3089–99. https://doi.org/10.1681/ASN.2017010108.
Article CAS PubMed PubMed Central Google Scholar
Yu GZ, Guo L, Dong JF, Shi SF, Liu LJ, Wang JW, et al. Persistent Hematuria and kidney disease progression in IgA nephropathy: a cohort study. Am J Kidney Dis. 2020;76(1):90–9. https://doi.org/10.1053/j.ajkd.2019.11.008.
Article CAS PubMed Google Scholar
Pitcher D, Braddon F, Hendry B, Mercer A, Osmaston K, Saleem MA, et al. Long-term outcomes in IgA nephropathy. Clin J Am Soc Nephrol. 2023;18(6):727–38. https://doi.org/10.2215/CJN.0000000000000135.
Article PubMed PubMed Central Google Scholar
Nakata J, Suzuki Y, Suzuki H, Sato D, Kano T, Yanagawa H, et al. Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy. PLoS ONE. 2014;9(2): e89707. https://doi.org/10.1371/journal.pone.0089707.
Article CAS PubMed PubMed Central Google Scholar
Suzuki H, Moldoveanu Z, Julian BA, Wyatt RJ, Novak J. Autoantibodies specific for galactose-deficient IgA1 in IgA vasculitis with nephritis. Kidney Int Rep. 2019;4(12):1717–24. https://doi.org/10.1016/j.ekir.2019.08.015.
Comments (0)